Mark W. Burket

Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison

Christopher B. Cooper, Reda A. El-Shiekh, David J. Cohen et al. · American Heart Journal · 1999 · 588 citations

Percutaneous Coronary Intervention, Cardiac Catheterization, Healthcare Value +13

Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease

Michael D. Dake, Gary M. Ansel, Michael R. Jaff et al. · Circulation Cardiovascular Interventions · 2011 · 561 citations

A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial

William A. Gray, Koen Keirse, Yoshimitsu Soga et al. · The Lancet · 2018 · 279 citations

Zilver Ptx, Paclitaxel-eluting Stent, Endovascular Technique +8

Embolic Protection and Platelet Inhibition During Renal Artery Stenting

Christopher J. Cooper, Steven T. Haller, William R. Colyer et al. · Circulation · 2008 · 170 citations

Renal artery angioplasty and stent placement: Predictors of a favorable outcome

Mark W. Burket, Christopher J. Cooper, David J. Kennedy et al. · American Heart Journal · 2000 · 133 citations

Urology, Cardiovascular Disease, Vascular Surgery +8